User profiles for Narihito Nagoshi
Narihito NagoshiKeio University School of Medicine Verified email at 2002.jukuin.keio.ac.jp Cited by 8742 |
Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow
…, S Suzuki, C Miyauchi-Hara, N Nagoshi… - Journal of Experimental …, 2009 - rupress.org
Mesenchymal stem cells (MSCs) are defined as cells that undergo sustained in vitro growth
and can give rise to multiple mesenchymal lineages. Because MSCs have only been …
and can give rise to multiple mesenchymal lineages. Because MSCs have only been …
Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury
…, K Fujiyoshi, M Mukaino, N Nagoshi… - Proceedings of the …, 2010 - National Acad Sciences
Various types of induced pluripotent stem (iPS) cells have been established by different
methods, and each type exhibits different biological properties. Before iPS cell-based clinical …
methods, and each type exhibits different biological properties. Before iPS cell-based clinical …
[PDF][PDF] Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad
Although recent reports have described multipotent, self-renewing, neural crest-derived stem
cells (NCSCs), the NCSCs in various adult rodent tissues have not been well characterized …
cells (NCSCs), the NCSCs in various adult rodent tissues have not been well characterized …
[HTML][HTML] Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice
…, N Suzuki, K Yamamura, N Nagoshi… - The Journal of …, 2011 - Am Soc Clin Investig
In chronic kidney disease, fibroblast dysfunction causes renal fibrosis and renal anemia.
Renal fibrosis is mediated by the accumulation of myofibroblasts, whereas renal anemia is …
Renal fibrosis is mediated by the accumulation of myofibroblasts, whereas renal anemia is …
A clinical practice guideline for the management of patients with degenerative cervical myelopathy: recommendations for patients with mild, moderate, and severe …
…, J Milligan, H Nakashima, N Nagoshi… - Global spine …, 2017 - journals.sagepub.com
Study Design: Guideline development. Objectives: The objective of this study is to develop
guidelines that outline how to best manage (1) patients with mild, moderate, and severe …
guidelines that outline how to best manage (1) patients with mild, moderate, and severe …
Development of mesenchymal stem cells partially originate from the neural crest
Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal stem cells isolated
from many adult tissues. Previous studies reported that MSCs can differentiate to both …
from many adult tissues. Previous studies reported that MSCs can differentiate to both …
Isolation of multipotent neural crest‐derived stem cells from the adult mouse cornea
S Yoshida, S Shimmura, N Nagoshi, K Fukuda… - Stem …, 2006 - academic.oup.com
We report the presence of neural crest‐derived corneal precursors (COPs) that initiate
spheres by clonal expansion from a single cell. COPs expressed the stem cell markers nestin, …
spheres by clonal expansion from a single cell. COPs expressed the stem cell markers nestin, …
A clinical practice guideline for the management of patients with acute spinal cord injury and central cord syndrome: recommendations on the timing (≤ 24 hours …
…, JW Middleton, H Nakashima, N Nagoshi… - Global spine …, 2017 - journals.sagepub.com
Objective: To develop recommendations on the timing of surgical decompression in patients
with traumatic spinal cord injury (SCI) and central cord syndrome. Methods: A systematic …
with traumatic spinal cord injury (SCI) and central cord syndrome. Methods: A systematic …
[HTML][HTML] First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol
…, S Ito, T Okubo, O Tsuji, S Nori, N Nagoshi… - Regenerative …, 2021 - Elsevier
Introduction Our group has conducted extensive basic and preclinical studies of the use of
human induced pluripotent cell (iPSC)-derived neural stem/progenitor cell (hiPSC-NS/PC) …
human induced pluripotent cell (iPSC)-derived neural stem/progenitor cell (hiPSC-NS/PC) …
A clinical practice guideline for the management of patients with acute spinal cord injury: recommendations on the use of methylprednisolone sodium succinate
…, JW Middleton, H Nakashima, N Nagoshi… - Global spine …, 2017 - journals.sagepub.com
Introduction: The objective of this guideline is to outline the appropriate use of methylprednisolone
sodium succinate (MPSS) in patients with acute spinal cord injury (SCI). Methods: A …
sodium succinate (MPSS) in patients with acute spinal cord injury (SCI). Methods: A …